Symbol="BCRX"
AssetType="Common Stock"
Name="BioCryst Pharmaceuticals Inc"
Description="BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina."
CIK="882796"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1451021000"
EBITDA="-125368000"
PERatio="None"
PEGRatio="-0.28"
BookValue="-1.738"
DividendPerShare="0"
DividendYield="0"
EPS="-1.25"
RevenuePerShareTTM="1.551"
ProfitMargin="-0.781"
OperatingMarginTTM="-0.438"
ReturnOnAssetsTTM="-0.153"
ReturnOnEquityTTM="-19.25"
RevenueTTM="289682000"
GrossProfitTTM="10936000"
DilutedEPSTTM="-1.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.378"
AnalystTargetPrice="15.15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="8.45"
PriceToBookRatio="56.59"
EVToRevenue="9.45"
EVToEBITDA="-23.51"
Beta="1.895"
num_52WeekHigh="15.43"
num_52WeekLow="6.82"
num_50DayMovingAverage="7.72"
num_200DayMovingAverage="9.71"
SharesOutstanding="188935000"
DividendDate="None"
ExDividendDate="None"
symbol="BCRX"
open="7.65"
high="7.88"
low="7.57"
price="7.68"
volume="1997347.00"
latest_trading_day="2023-07-28"
previous_close="7.75"
change="-0.07"
change_percent="-0.9032%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="2668996"
Change_recent_avg="-0.03"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-0.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="133"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="953"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_positive_thumbnail_id_2="681"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0027.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
